Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 60 Lymphoid 34 Myeloid 29 Plasma cell 26 Classical hematology 13 Genitourinary 2 CNS 2 Thoracic 1 Sarcoma 1 Other neoplasm 1 Other 1 Gastrointestinal 1 Dermatologic 1

Conditions

Obesity 373 Neoplasms 134 Breast Neoplasms 95 Mucositis 94 Overweight 91 Sexual Dysfunction, Physiological 90 Polycystic Ovary Syndrome 89 Dyspnea 56 Motor Activity 54 Weight Loss 38 Constipation 35 Diabetes Mellitus 33 Prostatic Neoplasms 32 Head and Neck Neoplasms 30 Colorectal Neoplasms 30 Endometrial Neoplasms 26 Lung Neoplasms 25 Depression 25 Diabetes Mellitus, Type 2 23 Cardiovascular Diseases 23 Multiple Endocrine Neoplasia Type 1 22 Pain 20 Anxiety Disorders 20 Insulin Resistance 19 Obesity, Morbid 18 Pulmonary Disease, Chronic Obstructive 17 Hypertension 17 Sexual Dysfunctions, Psychological 16 Metabolic Syndrome 16 Colonic Neoplasms 16

Interventions

Surveys and Questionnaires 1 Sugars 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hematologic Diseases × Other × Clear all

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡